Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14

NCT03404856 is registered in ClinicalTrials.gov with Orpha Labs as lead sponsor.

NCT NCT03404856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03404856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14
Lead sponsor
Orpha Labs
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 31, 2017
Completion date
October 31, 2019
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glycogen storage disease, type 14